XEED
LIVE

Serial Number

99225625

Owner

Xzom, Inc.

Attorney

Gina L. Durham

Filing Date

Jun 9, 2025

Add to watchlist:

No watchlists yet
View on USPTO

XEED Trademark

Serial Number: 99225625

XEED is a trademark filed by Xzom, Inc. on June 9, 2025. The trademark is classified under Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus), Class 44 (Medical Services). The application is currently pending registration.

Owner Contact Info

Xzom, Inc. (8 trademarks)

9381 Judicial Drive, Suite 120
San Diego, CA 92121

Entity Type: 03

Trademark Details

Filing Date

June 9, 2025

Registration Date

Not Registered

Goods & Services

Medical testing for diagnostic and treatment purposes

Medical apparatus and instrument for diagnostic use, namely, apparatus for medical diagnostic testing in the fields of autoimmune, cardiovascular, central nervous system, endocrine, gastrointestinal, genetic, infectious, inflammatory, kidney, liver, menopausal, metabolic, musculoskeletal, neurodegenerative, neurological, neuromuscular, respiratory, reproductive, and viral diseases and disorders; medical diagnostic apparatus for detecting autoimmune, cardiovascular, central nervous system, endocrine, gastrointestinal, genetic, infectious, inflammatory, kidney, liver, menopausal, metabolic, musculoskeletal, neurodegenerative, neurological, neuromuscular, respiratory, reproductive, and viral diseases and disorders; medical diagnostic apparatus, namely, lab-on-a-chip systems comprised of microelectrode arrays and microfluidic controllers, pumps, and valves for use in biological analysis; apparatus for carrying out diagnostic cell-based testing for medical purposes; diagnostic apparatus for autoimmune, cardiovascular, central nervous system, endocrine, gastrointestinal, genetic, infectious, inflammatory, kidney, liver, menopausal, metabolic, musculoskeletal, neurodegenerative, neurological, neuromuscular, respiratory, reproductive, and viral diseases and disorders, namely, medical diagnostic apparatus for testing cell-derived vesicles or extra-cellular vesicles and detecting autoimmune, cardiovascular, central nervous system, endocrine, gastrointestinal, genetic, infectious, inflammatory, kidney, liver, menopausal, metabolic, musculoskeletal, neurodegenerative, neurological, neuromuscular, respiratory, reproductive, and viral diseases and disorders; Medical apparatus and instrument for diagnostic use, namely, apparatus for medical diagnostic testing in the field of oncology; medical diagnostic apparatus for detecting cancer; diagnostic apparatus for cancer diseases, namely, medical diagnostic apparatus for testing cell-derived vesicles or extra-cellular vesicles and detecting cancer; none of the foregoing comprising wearable movement tracking devices.

Diagnostic kits comprised of medical diagnostic reagents and assays for testing of exosomes and other extra-cellular vesicles for use in disease detection, namely, autoimmune, cardiovascular, central nervous system, endocrine, gastrointestinal, genetic, infectious, inflammatory, kidney, liver, menopausal, metabolic, musculoskeletal, neurodegenerative, neurological, neuromuscular, respiratory, reproductive, and viral diseases and disorders; medical diagnostic reagents and assays for testing of exosomes and other extra-cellular vesicles in the fields of autoimmune, cardiovascular, central nervous system, endocrine, gastrointestinal, genetic, infectious, inflammatory, kidney, liver, menopausal, metabolic, musculoskeletal, neurodegenerative, neurological, neuromuscular, respiratory, reproductive, and viral diseases and disorders

Filing History

TEAS/EMAIL CORRESPONDENCE ENTERED
Jan 30, 2026 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jan 30, 2026 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jan 30, 2026 TROA
APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Jan 29, 2026 XELG
APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Jan 29, 2026 XELR
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Oct 30, 2025 GNRN
NON-FINAL ACTION E-MAILED
Oct 30, 2025 GNRT
NON-FINAL ACTION WRITTEN
Oct 30, 2025 CNRT
ASSIGNED TO EXAMINER
Oct 29, 2025 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Oct 15, 2025 NWOS
APPLICATION FILING RECEIPT MAILED
Jun 9, 2025 MAFR
NEW APPLICATION ENTERED
Jun 9, 2025 NWAP